• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Justice...

Unfortunately the senior management at Osteohealth did not value real relationships and true leadership and they put trust in a pharma robot and paid the ultimate price. RIP Dennis G. Maybe you can troll the school yards and shake down lunch money now.

tough lesson for once a great company. The origional team members are thriving within the same industry. The Pharma Pucks are scrambling like the snakes snakes they are.
 




DG is now the global sales leader. Let's see how long that'll last. 4 reps were let go and now there's only 8 with significantly larger territories. GEM will be sold soon. Morale is beyond low as everyone is looking. No $ to be made here, always a change in bonus structure which is taking $ away. DON'T join!!!
 




DG is now the global sales leader. Let's see how long that'll last. 4 reps were let go and now there's only 8 with significantly larger territories. GEM will be sold soon. Morale is beyond low as everyone is looking. No $ to be made here, always a change in bonus structure which is taking $ away. DON'T join!!!

thought DG was long gone
 




DG is now the global sales leader. Let's see how long that'll last. 4 reps were let go and now there's only 8 with significantly larger territories. GEM will be sold soon. Morale is beyond low as everyone is looking. No $ to be made here, always a change in bonus structure which is taking $ away. DON'T join!!!

Global sales leader of what? Luitpold/OHD isn't a global company.